SCHEMBL5772959

SCHEMBL5772959

Cc1cccnc1Nc1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.58
KMT2A Q03164 4/20 0.53
MEN1 O00255 2/20 0.53
MAPK10 P53779 1/20 0.53
GFER P55789 1/20 0.53
NPC1 O15118 5/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
HTT P42858 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
LMNA P02545 1/20 0.51
HSP90AA1 P07900 1/20 0.51
SLC2A1 P11166 1/20 0.51
NFKB1 P19838 1/20 0.51
AGTR1 P30556 1/20 0.51
OPRK1 P41145 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
RAB9A P51151 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15368480 0.83 NPC1 (0.61) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL7941542 0.78 MAPK10 (0.73) KMT2AMEN1MAPK10GFERNPC1
SCHEMBL31220877 0.78 MAPK10 (0.73) KMT2AMEN1MAPK10GFERNPC1
SCHEMBL7982557 0.78 NPC1 (0.52) KMT2AMEN1MAPK10GFERNPC1
SCHEMBL7236672 0.78 NPC1 (0.60) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL3953162 0.78 NPC1 (0.55) KMT2AMEN1NPC1KDM4EMAPT
SCHEMBL10094589 0.78 GRM5 (0.50) GRM5KMT2AMEN1NPC1KDM4E
SCHEMBL10094602 0.78 MAPT (0.45) GRM5KMT2AMEN1NPC1KDM4E
SCHEMBL29783966 0.78 IGF1R (0.55) KMT2AMEN1NPC1KDM4EHTT
SCHEMBL23319547 0.77 GRM5 (0.54) GRM5KMT2AMEN1MAPK10GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027321-A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 MERCK SHARP & DOHME CORP. 2007-02-01 US disclosed
US-20060293503-A1 Polyaminopyridines and method for producing same SUMITOMO SEIKA CHEMICALS CO., LTD (JP) 2006-12-28 US disclosed
EP-1669390-A1 POLYAMINOPYRIDINES AND METHOD FOR PRODUCING SAME SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2006-06-14 EP disclosed
US-20060058178-A1 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions DEGUSSA AG (DE) 2006-03-16 US disclosed
EP-1446224-B1 AROMATIC COMPOUNDS CONTAINING NITROGEN AND P-FUNCTIONALIZED AMINES, THE PRODUCTION THEREOF AND THEIR USE IN CATALYTIC REACTIONS DEGUSSA (DE) 2006-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058178-A1 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions PAH, PNMT, TYR GRM5 4477/4885KMT2A 943/4885MEN1 3253/4885
US-20070027321-A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 GRM5, GRIK5, GRM1 GRM5 1/4885KMT2A 721/4885MEN1 4674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.